Heran Partners

Heran Partners, founded in 2020 and based in Antwerp, Belgium, is a venture capital firm focusing on MedTech and HealthTech ventures. Their mission is to fuel the growth of innovative technologies at the intersection of life sciences and data. They support startups and scale-ups that develop disruptive innovations ranging from medical devices to AI solutions for diagnostics and patient monitoring. Heran Partners has a strategic investment approach, targeting key drivers in healthcare such as the need for insightful data, cost-effective solutions, and personalized medicine. The fund typically invests up to EUR 5 million in early-stage companies, offering not only financial support but also strategic guidance, scientific expertise, and a strong network to maximize the ventures' potential. Notable investments include companies like Icometrix, which uses AI to quantify brain structures from MR and CT scans, and Hypervision Surgical, an advanced surgical imaging and data analytics platform. The fund has also seen successful exits, including BlueBee and PharmaFluidics. The team is led by experienced professionals like Annie Vereecken, a serial life sciences entrepreneur, Katleen Vandersmissen, Herman Verrelst, and Joris Mortelmans. They emphasize building long-term relationships with their portfolio companies, growing hand-in-hand with founders and management teams. Heran Partners actively co-invests with other venture capital firms to leverage complementary skills and networks, positioning themselves as a key player in the European HealthTech investment landscape​.